Expression of complement inhibitors CD46, CD55, and CD59 on tumor cells does not predict clinical outcome after rituximab treatment in follicular non-Hodgkin lymphoma

請用此 Handle URI 來引用此文件： http://scholars.ntou.edu.tw/handle/123456789/1374

標題:	Expression of complement inhibitors CD46, CD55, and CD59 on tumor cells does not predict clinical outcome after rituximab treatment in follicular non-Hodgkin lymphoma
作者:	Wen-Kai Weng Levy, R.
公開日期:	九月-2001
卷:	98
期:	5
來源出版物:	Blood
URI:	http://scholars.ntou.edu.tw/handle/123456789/1374
ISSN:	0006-4971
DOI:	10.1182/blood.V98.5.1352 ://WOS:000170685000014
顯示於：	河海工程學系

顯示文件完整紀錄

上周
0

上個月
0

checked on 2022/10/13

檢查

TAIR相關文章